ArticleGut2005

Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95L mediated control of minimal residual disease.

J Sträter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.